MedPath

Concussion Recovery and Support Program

Not Applicable
Not yet recruiting
Conditions
Brain Concussion
Mild Traumatic Brain Injury
Headache
Registration Number
NCT07097792
Lead Sponsor
Seattle Children's Hospital
Brief Summary

Pilot randomized controlled trial (RCT) comparing a novel intervention Concussion Recovery and Support Program (CRISP) for adolescents and young adults (AYA) 18-30 yo with concussion/ mild TBI.

Detailed Description

We are conducting a pilot study to examine the feasibility, acceptability and pilot efficacy of a novel intervention called CRISP for young adults with persistent concussion/ mTBI. CRISP is an adaptation of an evidence-based treatment for chronic pain called Emotional Awareness and Expression Therapy (EAET). EAET targets underlying emotional responses that appear to drive persistent symptoms, and has been found effective for treating headache and other types of pain in randomized controlled trials with moderately strong effect sizes (0.4-0.5).

Individuals who participate in this study will complete 8 sessions of CRISP with a trained therapist over zoom (each 60 minutes) and will also fill out surveys at multiple time points (baseline, 4 weeks, 8 weeks).

Aim 1: Evaluate feasibility and acceptability of CRISP with a pilot study of n=40 individuals with concussion ages 18-30 years. Hypothesis: CRISP will be a feasible and acceptable approach to treating AYA with concussion.

Aim 2: Collect pilot data regarding efficacy of CRISP for reducing concussion symptoms and improving function. Hypothesis: Pilot data may show benefit from this approach for improving recovery, though we do not expect significance given the sample size.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Diagnosed with a concussion and at least 2 weeks from injury but less than one year.
  • New or worsening headache since concussion
  • Had at least one day with headache last week of moderate severity or two days with headache of any severity
Exclusion Criteria
  • Non-English speaking
  • Acute mental health issues such as active suicidality, psychiatric hospitalization within the past 6 months, ER visit for suicidality in the past 6 months or experiencing psychosis or delusions

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Treatment Evaluation Inventory, short form8 weeks

Self-report form regarding acceptability of treatment approach

Secondary Outcome Measures
NameTimeMethod
HIT6 (Headache Impact Test, 6 item)Baseline, 4 weeks, 8 weeks (trajectory over time)

Self-report measure of headache severity

Chronic Headache Quality of Life Questionnaire (CHQLQ)Baseline/ 4 weeks/ 8 weeks (Trajectory over time)

Self-report measure of headache severity with a particular focus on impact on QoL

Fatigue and Altered Cognition Scale (FACS)Baseline/ 4 weeks/ 8 weeks (trajectory over time)

20 item self-report scale measuring issues with fatigue and cognition

Fear of Concussive Symptoms Questionnaire (FOCSQ)Baseline/ 4 weeks/ 8 weeks (trajectory over time)

Self-report measure of fear-avoidance of activities due to concussive symptoms

Post Concussion Symptom Scale (PCSS)Baseline/ 4 weeks/ 8 weeks (trajectory over time)

Self-report measure of concussive symptoms

Headache severity and frequency (HQ)Baseline/ 4 weeks/ 8 weeks (trajectory over time)

3 item scale to rate frequency, severity and bothersomeness of headaches

PROMIS anxietyBaseline/ 4 weeks/ 8 weeks (trajectory over time)

8 item scale to measure self-report of anxiety

PROMIS depressionBaseline/ 4 weeks/ 8 weeks (trajectory over time)

8 item scale to measure self-report of depressive symptoms

Emotional Approach Coping (EAC)Baseline/ 4 weeks/ 8 weeks (trajectory over time)

Self-report survey to measure ability to acknowledge and express emotion

Psychological InsightBaseline/ 4 weeks/ 8 weeks (trajectory over time)

6 item self-report scale to measure psychological insight

Pittsburgh Sleep Quality Inventory (PSQI)Baseline/ 4 weeks/ 8 weeks (trajectory over time)

Self-report measure of sleep quality

Brief Irritability Test (BITe)Baseline/ 4 weeks/ 8 weeks (trajectory over time)

5 item measure of irritability

Trial Locations

Locations (2)

Seattle Children's Research Institute

🇺🇸

Seattle, Washington, United States

University of Washington

🇺🇸

Seattle, Washington, United States

Seattle Children's Research Institute
🇺🇸Seattle, Washington, United States
Sara P Chrisman, MD MPH
Contact
206-884-1490
crisp@seattlechildrens.org

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.